Joost B. Vos

Joost B. Vos

Auto-generated profile, based on publicly available information

Joost B. Vos

Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2009 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
CSCoen van Solingen
Coen van Solingen
LSLeonard Seghers
Leonard Seghers
RBRoel Bijkerk
Roel Bijkerk
JDJacques M.G.J. Duijs
Jacques M.G.J. Duijs
MRMarko K. Roeten
Marko K. Roeten
AZAnton-Jan van Zonneveld
Anton-Jan van Zonneveld
MicroRNAs are negative regulators of gene expression that play a key role in cell‐type specific differentiation and modulation of cell function and have been proposed to be involved in neovascularization. Previously, using an extensive cloning and sequencing approach, we identified miR‐126 to be specifically and highly expressed in human endothelial cells (EC). Here, we demonstrate EC‐specific expression of miR‐126 in capillaries and the larger vessels in vivo. We therefore explored the potential role of miR‐126 in arteriogenesis and angiogenesis. Using miR‐reporter constructs, we show that miR‐126 is functionally active in EC in vitro and that it could be specifically repressed using antagomirs specifically targeting miR‐126. To study the consequences of miR‐126 silencing on vascular regeneration, mice were injected with a single dose of antagomir‐126 or a control ‘scramblemir’ and exposed to ischemia of the left hindlimb by ligation of the femoral artery. Although miR‐126 was effectively silenced in mice treated with a single, high dose (HD) of antagomir‐126, laser Doppler perfusion imaging did not show effects on blood flow recovery. In contrast, quantification of the capillary density in the gastrocnemius muscle revealed that mice treated with a HD of antagomir‐126 had a markedly reduced angiogenic response. Aortic explant cultures of the mice confirmed the role of miR‐126 in angiogenesis. Our data demonstrate a facilitary function for miR‐126 in ischemia‐induced angiogenesis and show the efficacy and specificity of antagomir‐induced silencing of EC‐specific microRNAs in vivo.

5 September 2006 in Genome Research
Verified
Journal Article
Closed access
PDF file
EBEugene Berezikov
Eugene Berezikov
GTGeert van Tetering
Geert van Tetering
MVMark Verheul
Mark Verheul
JBJose van de Belt
Jose van de Belt
LLLinda van Laake
Linda van Laake
ECEdwin Cuppen
Edwin Cuppen
IcroRNAs are 20- to 23-nucleotide RNA molecules that can regulate gene expression. Currently >400 microRNAs have been experimentally identified in mammalian genomes, whereas estimates go up to 1000 and beyond. Here we show that many more mammalian microRNAs exist. We discovered novel microRNA candidates using two approaches: testing of computationally predicted microRNAs by a modified microarray-based detection system, and cloning and sequencing of large numbers of small RNAs from different human and mouse tissues. Together these efforts experimentally identified 348 novel mouse and 81 novel human microRNA candidate genes. Most novel microRNAs candidates are not conserved beyond mammals, and ~10% are taxon-specific. Our analyses indicate that the entire microRNA repertoire is not remotely exhausted.

13 November 2014 in Nature Communications
Verified
Journal Article
Open access
LVLisa T. C. Vogelpoel
Lisa T. C. Vogelpoel
IHIvo S. Hansen
Ivo S. Hansen
TRTheo Rispens
Theo Rispens
FMFemke J. M. Muller
Femke J. M. Muller
TCToni M. M. van Capel
Toni M. M. van Capel
JDJeroen den Dunnen
Jeroen den Dunnen
M2 macrophages suppress inflammation in numerous disorders, including tumour formation, infection and obesity. However, the exact role of M2 macrophages in the context of several other diseases is still largely undefined. We here show that human M2 macrophages promote inflammation instead of suppressing inflammation on simultaneous exposure to complexed IgG (c-IgG) and TLR ligands, as occurs in the context of diseases such as rheumatoid arthritis (RA). c-IgG-TLR ligand co-stimulation of M2 macrophages selectively amplifies production of pro-inflammatory cytokines TNF-α, IL-1β and IL-6 and promotes Th17 responses, which all play a critical role in RA pathology. Induction of pro-inflammatory cytokines on c-IgG co-stimulation mainly depends on Fc gamma receptor IIa (FcγRIIa), which selectively amplifies cytokine gene transcription and induces caspase-1 activation. These data indicate that FcγR-TLR cross-talk may be targeted for treatment to attenuate inflammation in RA, by restoring the anti-inflammatory function of M2 macrophages.

7 February 2006 in Journal of Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
MMM. C. Morsink
M. C. Morsink
PSP. J. Steenbergen
P. J. Steenbergen
JVJ. B. Vos
J. B. Vos
HKH. Karst
H. Karst
MJM. Joëls
M. Joëls
NDN. A. Datson
N. A. Datson

20 October 2006 in Aging Cell
Verified
Journal Article
Closed access
PDF file
DTDick H. J. Thijssen
Dick H. J. Thijssen
JVJoost B. Vos
Joost B. Vos
CVCaroline Verseyden
Caroline Verseyden
AZAnton-Jan van Zonneveld
Anton-Jan van Zonneveld
PSPaul Smits
Paul Smits
HBHetty C. De Boer
Hetty C. De Boer

17 April 2013 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
ARArie Reijerkerk
Arie Reijerkerk
MLM. Alejandro Lopez-Ramirez
M. Alejandro Lopez-Ramirez
BHBert van Het Hof
Bert van Het Hof
JDJoost A.R. Drexhage
Joost A.R. Drexhage
WKWouter W. Kamphuis
Wouter W. Kamphuis
HVHelga E. de Vries
Helga E. de Vries
Blood–brain barrier (BBB) dysfunction is a major hallmark of many neurological diseases, including multiple sclerosis (MS). Using a genomics approach, we defined a microRNA signature that is diminished at the BBB of MS patients. In particular, miR-125a-5p is a key regulator of brain endothelial tightness and immune cell efflux. Our findings suggest that repair of a disturbed BBB through microRNAs may represent a novel avenue for effective treatment of MS.